Touloukian James S MD is categorized under Gastroenterologists in Bloomington, IN and active since 2007.
Touloukian James S MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Gastroenterologists business, which does work in the B2C market, and is classified as a Gastroenterologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact James Touloukian at the company’s single location by writing to 550 South Landmark Avenue, Bloomington, Indiana IN 47403 or by phoning (812) 355-6900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Touloukian James S MD |
| Contact Person: | James Touloukian |
| Address: | 550 South Landmark Avenue, Bloomington, Indiana 47403 |
| Phone Number: | (812) 355-6900 |
| Website Address: | ima-md.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Gastroenterologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Touloukian James S MD was started in 2007 to provide professional Gastroenterologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact James Touloukian for inquiries that concern Touloukian James S MD by calling the company number (812) 355-6900, as your correspondence is most welcome. Additionally, the physical location of the single location of Touloukian James S MD can be found at the coordinates 39.16139,-86.55444 as well as the street address 550 South Landmark Avenue in Bloomington, Indiana 47403.
For its online presence, you may visit Touloukian James S MD’s website at ima-md.com and engage with its social media outlets through on Twitter and on Facebook.